The circKIF4A-miR-375-KIF4A axis regulates TNBC progression via the competitive endogenous RNA (ceRNA) mechanism. circKIF4A may therefore serve as a prognostic biomarker and therapeutic target for TNBC.
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.